V009-4115 Screening compound: N-[3-(2-methylpiperidin-1-yl)propyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide

V009-4115 Screening compound: N-[3-(2-methylpiperidin-1-yl)propyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide
V009-4115 Screening compound: N-[3-(2-methylpiperidin-1-yl)propyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-4115
N-[3-(2-methylpiperidin-1-yl)propyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-4115

Molecular Formula

C30H39N5O (C30 H39 N5 O)

Compound Name

N-[3-(2-methylpiperidin-1-yl)propyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide

IUPAC name

N-[3-(2-methylpiperidin-1-yl)propyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide

SMILES

CC1N(CCCNC(c(cc2)ccc2-c2cc(-c(cc3)ccc3N3CCCCC3)n[nH]2)=O)CCCC1

InChI

InChI=1S/C30H39N5O/c1-23-8-3-6-18-34(23)21-7-17-31-30(36)26-11-9-24(10-12-26)28-22-29(33-32-28)25-13-15-27(16-14-25)35-19-4-2-5-20-35/h9-16,22-23H,2-8,17-21H2,1H3,(H,31,36)(H,32,33)/t23-/m0/s1

InChI Key

DUYJKUYYIJXJPP-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD19954175

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

485.67

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.258

Distribution Coefficient, logD

2.410

Water Solubility, LogSw

-4.96

Polar Surface Area

53.597

Acid Dissociation Constant (pKa)

12.69

Base Dissociation Constant (pKb)

10.25

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

46.70

V009-4115 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V009-4115 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-4115?
Check Price and Availability of V009-4115, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-4115 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-4115
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-4115
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-4115 available by request